November 19, 2012 / 6:26 AM / in 5 years

Belgium's IBA posts 14 pct revenue growth in Q3

BRUSSELS, Nov 19 (Reuters) - Belgian cancer treatment equipment maker IBA said revenues in the third quarter grew by 14 percent, driven by a strong performance of its equipment division.

Revenues in the third quarter came in at 180.1 million euros ($228.83 million), 155.5 million of which was booked by the equipment unit.

The group said it expects to achieve revenue growth of 5 to 10 percent a year over the next three years, supported by a strong order book. ($1 = 0.7871 euros) (Reporting By Robert-Jan Bartunek)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below